Unither Pharmaceuticals Email Format
Pharmaceutical ManufacturingÎle-de-france, France1001-5000 Employees
Unither Pharmaceuticals operates as a global contract manufacturer focused on sterile unit-dose production for the pharmaceutical industry. Based in the Paris region of France, the company runs eight manufacturing plants across France, the United States, Brazil, and China, with several commercial offices and an R&D platform supporting its operations. It supplies pharmaceutical companies with a range of sterile and specialty dosage forms, distributing products to customers in more than 100 countries. Within the pharmaceutical manufacturing landscape, Unither is positioned as a specialist provider of sterile unit-dose capabilities that enable scalable production for a variety of clinical and commercial programs. In May 2026, the company announced the appointment of Henrik Krüpper as chief executive, marking a leadership change as it continues to expand its international footprint. With its base in Paris and a broad global footprint, Unither collaborates with pharmaceutical customers to develop and manufacture sterile-dose products.